Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inogen IncINGN · Entity 2083 | EVP, Engineering | September 28, 2021 | September 30, 2021 |
| Sight Sciences, Inc.SGHT · Entity 5537 | EVP, Operations & R&D | October 02, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inogen Inc
Report date September 28, 2021 · Filed September 30, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 69,735 |
Reported balance
After 2021-09-28 transaction · row 1
1 source rowRow 1 · 2021-09-28 · Exercise / conversion · Acquired 12,945 · Balance 69,735 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.81 · Expires 2022-03-27 | Direct | 0 |
Reported balance
After 2021-09-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-09-28 · Exercise / conversion · Disposed 12,945 · Balance 0 F1: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2012. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 842 |
Reported balance
Holding disclosure · report date 2021-09-28 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 842 |
Filing footnotes · ownership attribution and instrument terms
F1: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2012.
Sight Sciences, Inc.
Report date October 02, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 261,990 |
Reported balance
After 2026-10-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-02 · Sale · Disposed 2,988 · Balance 261,990 F1: Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). F2: Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $8.68 to $9.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: Includes (i) 41,602 shares of Common Stock, and (ii) 220,388 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").
F2: Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $8.68 to $9.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: Includes (i) 41,602 shares of Common Stock, and (ii) 220,388 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2017 Filed Mar 4, 2017 00:05 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 200 | $77.66 | $15,532.00 |
DisclosureSEC source: 0001209191-17-018034 · doc4.xml · nonDerivative · entry 6 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 2,542 F5 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on September 2, 2016. F7 · price: Represents the weighted average share price of an aggregate total of 200 shares sold in the price range of $77.60 to $77.72 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 01, 2017 Filed Mar 4, 2017 00:05 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,850 | $75.05 | $138,833.44 |
DisclosureSEC source: 0001209191-17-018034 · doc4.xml · nonDerivative · entry 5 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 2,742 F5 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on September 2, 2016. F6 · price: Represents the weighted average share price of an aggregate total of 1,850 shares sold in the price range of $75.00 to $75.43 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 01, 2017 Filed Mar 4, 2017 00:05 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 200 | $77.59 | $15,517.00 |
DisclosureSEC source: 0001209191-17-018034 · doc4.xml · nonDerivative · entry 4 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,851 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2016. F4 · price: Represents the weighted average share price of an aggregate total of 200 shares sold in the price range of $77.46 to $77.71 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price Read SEC document |
| March 01, 2017 Filed Mar 4, 2017 00:05 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 400 | $76.52 | $30,608.00 |
DisclosureSEC source: 0001209191-17-018034 · doc4.xml · nonDerivative · entry 3 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,051 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2016. F3 · price: Represents the weighted average share price of an aggregate total of 400 shares sold in the price range of $76.08 to $76.98 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price Read SEC document |
| March 01, 2017 Filed Mar 4, 2017 00:05 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,826 | $75.04 | $212,053.43 |
DisclosureSEC source: 0001209191-17-018034 · doc4.xml · nonDerivative · entry 2 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,451 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 2,826 shares sold in the price range of $75.00 to $75.42 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 01, 2017 Filed Mar 4, 2017 00:05 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 3,426 | $38.54 | $132,038.04 |
DisclosureSEC source: 0001209191-17-018034 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 02:18 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 3,750 | $70.07 | $262,771.13 |
DisclosureSEC source: 0001209191-17-016232 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 4,592 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on September 2, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 3,750 shares sold in the price range of $70.00 to $70.31 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 20, 2017 Filed Jan 24, 2017 01:19 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 138 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-17-005212 · doc4.xml · derivative · entry 3 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 138 shares Expires 2017-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014. F2 · balance_after: 1,169 of the unvested shares subject to the options were forfeited in accordance with the terms of the award upon the reporting person's spouse's termination as a service provider, effective as of October 28, 2016. Read SEC document |
| January 20, 2017 Filed Jan 24, 2017 01:19 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 138 | $16.62 | $2,293.56 |
DisclosureSEC source: 0001209191-17-005212 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 8,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 10, 2017 Filed Jan 12, 2017 22:56 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 5,105 | $65.31 | $333,431.03 |
DisclosureSEC source: 0001209191-17-003552 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 8,204 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 5,105 shares sold in the price range of $65.08 to $65.54 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 20:05 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 31,823 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001209191-17-001872 · doc4.xml · derivative · entry 6 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,823 shares Expires 2018-03-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is January 1, 2008. F6 · derivative.expiration_date: Previous forms 3 and 4 reported the expiration date incorrectly. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 20:05 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 105 | $67.36 | $7,072.95 |
DisclosureSEC source: 0001209191-17-001872 · doc4.xml · nonDerivative · entry 4 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,851 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2016. F4 · price: Represents the weighted average share price of an aggregate total of 105 shares sold in the price range of $67.35 to $67.59 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 20:05 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 6,360 | $66.29 | $421,633.66 |
DisclosureSEC source: 0001209191-17-001872 · doc4.xml · nonDerivative · entry 3 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,956 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2016. F3 · price: Represents the weighted average share price of an aggregate total of 6,360 shares sold in the price range of $66.10 to $67.08 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 20:05 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 25,358 | $65.53 | $1,661,669.17 |
DisclosureSEC source: 0001209191-17-001872 · doc4.xml · nonDerivative · entry 2 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,316 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 25,358 shares sold in the price range of $65.10 to $66.09 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 20:05 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 31,823 | $2.40 | $76,375.20 |
DisclosureSEC source: 0001209191-17-001872 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,674 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2016 Filed Dec 27, 2016 18:22 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 79 | $0.00 Strike: $8.37 | $0.00 |
DisclosureSEC source: 0001209191-16-156779 · doc4.xml · derivative · entry 5 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 79 shares Expires 2017-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is October 1, 2013. F4 · balance_after: 474 of the unvested shares subject to the options were forfeited in accordance with the terms of the award upon the reporting person's spouse's termination as a service provider, effective as of October 28, 2016. Read SEC document |
| November 25, 2016 Filed Dec 27, 2016 18:22 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 625 | $0.00 Strike: $1.17 | $0.00 |
DisclosureSEC source: 0001209191-16-156779 · doc4.xml · derivative · entry 4 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 625 shares Expires 2017-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is January 1, 2013. F2 · balance_after: 938 of the unvested shares subject to the options were forfeited in accordance with the terms of the award upon the reporting person's spouse's termination as a service provider, effective as of October 28, 2016. Read SEC document |
| November 25, 2016 Filed Dec 27, 2016 18:22 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 79 | $8.37 | $661.23 |
DisclosureSEC source: 0001209191-16-156779 · doc4.xml · nonDerivative · entry 2 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 13,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2016 Filed Dec 27, 2016 18:22 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 625 | $1.17 | $731.25 |
DisclosureSEC source: 0001209191-16-156779 · doc4.xml · nonDerivative · entry 1 Taylor Brenton · CIK 0001596103 · EVP, Engineering 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 13,230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.